Curis Reports First Quarter 2021 Financial Results

Go back to Curis Reports First Quarter 2021 Financial Results

Curis (CRIS) Misses Q1 EPS by 2c

May 12, 2021 4:04 PM EDT

Curis (NASDAQ: CRIS) reported Q1 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $2.19 million versus the consensus estimate of $2.64 million.

"The first quarter of 2021 saw continued momentum for our pipeline of next generation targeted cancer therapies designed to meaningfully improve and extend patients' lives. We continued to make important progress with... More